Patritumab deruxtecan shows activity in EGFR-mutant NSCLC

Nature Reviews Clinical Oncology, Published online: 25 September 2023; doi:10.1038/s41571-023-00822-6Patritumab deruxtecan shows activity in EGFR-mutant NSCLC

https://www.nature.com/articles/s41571-023-00822-6

Source: Nature Reviews Clinical Oncology - September 25, 2023 Category: Cancer & Oncology Authors: Peter Sidaway Source Type: research

More News: Cancer & Oncology | Non-Small Cell Lung Cancer